# Nanjing Sainuo Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nanjing-sainuo-biotechnology-co

- Industry: Biotechnology
- Headquarters: Nanjing, China
- Latest round: Angel (Jan 24, 2019)
- Investors on record: 2

## About

Established in 2018 and based in Nanjing, China, Nanjing Sainuo Biotechnology Co., Ltd. is a company that focuses on the development of biological drugs for diabetes. In March 2020, the firm closed a pre-series A funding.

The company's main products include GLP-1 and insulin biopharmaceuticals. Its products are used to treat diabetes.

The company’s revenue is generated by providing biologic drugs for diabetes.

## Funding rounds

- Angel, Jan 24, 2019 — Dynamic Capital, Jiangsu Deyuan Pharmaceutical Co., Ltd

## Investors

- Dynamic Capital (https://capitalatlas.ai/funds/dynamic-capital) — Angel
- Jiangsu Deyuan Pharmaceutical Co., Ltd — Angel